Eagle Pharmaceuticals to Present at the Barclays Global
WOODCLIFF LAKE, N.J., March 09, 2023 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott......
Acutus Medical to Announce Fourth Quarter and Full Year
CARLSBAD, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on......
Vertex Energy, Inc. (VTNR) Shareholder Notice: Robbins LLP
SAN DIEGO, March 09, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons......
Match Group, Inc. (MTCH) Shareholder Notice: Robbins LLP
SAN DIEGO, March 09, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons......
Fidelity National Information Services, Inc. (FIS)
SAN DIEGO, March 09, 2023 (GLOBE NEWSWIRE) -- The Class: Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons......
ATN to Present at Sidoti Spring 2023 Small Cap Virtual
BEVERLY, Mass., March 09, 2023 (GLOBE NEWSWIRE) -- ATN International, Inc. (Nasdaq: ATNI), a leading provider of digital infrastructure and......
After Navigating Local Economic Hurdles, Small Businesses
When underserved communities couldn’t launch local startups, LPL Financial Foundation, LISC San Diego, Vista Chamber of Commerce and the University of San......
Shift to Report Fourth Quarter 2022 Financial Results on
SAN FRANCISCO, March 09, 2023 (GLOBE NEWSWIRE) -- Shift (Nasdaq: SFT), a leading end-to-end auto ecommerce platform transforming the used car industry......
Katapult Announces Fourth Quarter 2022 Financial Results
PLANO, Texas, March 09, 2023 (GLOBE NEWSWIRE) -- Katapult Holdings, Inc. (“Katapult” or the “Company”) (NASDAQ: KPLT), an e-commerce-focused financial......
MacroGenics Announces Sale of TZIELD™ Royalty Interest for
ROCKVILLE, MD, March 08, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and......